Lab Essentials was Alpha Teknova’s largest product and service line in fiscal 2025, bringing in $31.04M of $40.52M (77%).
| Product and Service | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|
| Lab Essentials | $31.77M | $28.80M | $28.88M | $31.04M | ||
| Clinical Solutions | $8.45M | $6.74M | $7.10M | $7.65M | ||
| Sample Transport | — | — | — | — | ||
| Other | $1.20M | $1.15M | $1.77M | $1.83M | ||
| Total | $41.42M | $36.68M | $37.75M | $40.52M |
Alpha Teknova brought in $40.52M from its three product and service lines in fiscal 2025, the year ended December 31, 2025. That was up 7.4% from $37.75M in fiscal 2024. Lab Essentials was the largest at $31.04M (76.6%), ahead of Clinical Solutions at $7.65M (18.9%) and Other at $1.83M (4.5%).
Compared with fiscal 2024, Clinical Solutions grew fastest, up 7.8% to $7.65M. Every line above 2% of revenue grew. From fiscal 2022 to 2025, combined revenue from these lines fell from $41.42M to $40.52M, a compound annual decline of 0.7%. Lab Essentials' share held steady at about 76.6%.
United States was Alpha Teknova’s largest region in fiscal 2025, bringing in $38.25M of $40.52M (94%).
| Geography | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|
| United States | $40.10M | $35.00M | $35.92M | $38.25M | ||
| International | $1.32M | $1.68M | $1.83M | $2.27M | ||
| Total | $41.42M | $36.68M | $37.75M | $40.52M |
Alpha Teknova brought in $40.52M from its two regions in fiscal 2025, the year ended December 31, 2025. That was up 7.4% from $37.75M in fiscal 2024. United States was the largest at $38.25M (94.4%), ahead of International at $2.27M (5.6%).
Compared with fiscal 2024, International grew 24.4% to $2.27M and United States grew 6.5% to $38.25M. From fiscal 2022 to 2025, combined revenue from these regions fell from $41.42M to $40.52M, a compound annual decline of 0.7%. United States' share of the total fell from 96.8% to 94.4%.
Alpha Teknova (TKNO) reports its revenue by product and service and by geography. In fiscal 2025, Lab Essentials was its largest product and service line, bringing in $31.04M (76.6% of the total), followed by Clinical Solutions at $7.65M (18.9%).
Lab Essentials was Alpha Teknova's largest product and service line in fiscal 2025, bringing in $31.04M, or 76.6% of the $40.52M total across its three product and service lines.
United States was Alpha Teknova's largest region in fiscal 2025, bringing in $38.25M, or 94.4% of the $40.52M total across its two regions.
Among Alpha Teknova's product and service lines that make up at least 2% of revenue, Clinical Solutions grew fastest in fiscal 2025, up 7.8% from $7.10M to $7.65M.
Every figure comes from Alpha Teknova's annual financial filings, as reported. Each line keeps the name Alpha Teknova gives it, and years follow its fiscal calendar.
Alpha Teknova's revenue by product and service goes back to fiscal 2020, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.